3rd Quarter - Report

KOUNTOUPES DENHAM CARR & REID, LLC for INTEL CORPORATION

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 21, 2019 $50,000 Replaced
3rd Quarter - Amendment Mar 29, 2021 $50,000 Yes

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to trade, customs and trade facilitation as they relate to the semi-conductor industry.

Contacted: White House Office; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Telecommunications TEC

The development of smart, integrated systems and devices including the Internet of Things and Artificial Intelligence. Issues related to consumer privacy, 5G and autonomous vehicles. CPU security-related issues. Issues related to federal technology acquisition and use.

Contacted: Food & Drug Administration (FDA); White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Copyright/Patent/Trademark CPT

Issues related to intellectual property protection and patent reform. Issues related to Standard Essential Patents.

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); White House Office

Health Issues HCR

Issues related to the application of Artificial Intelligence in health care. Issues related to the implementation and adoption of health information technology, genomics and precision medicine.

Contacted: Health & Human Services, Dept of (HHS); White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Computer Industry CPI

Innovation and competitive issues as they affect the semi-conductor industry, spectrum policy, privacy and cybersecurity. Issues relating to prioritizing fundamental science, basic research and development and exascale computing.

LobbyistCovered position, as disclosed
LORI DENHAM —
MJ KENNY —
LISA KOUNTOUPES —
DAVID PAUL PELUSO —
MARY R "RANDI" REID —
ROSE SULLIVAN (LISTED IN ERROR) —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); White House Office; Health & Human Services, Dept of (HHS)

Science/Technology SCI

Issues relating to prioritizing fundamental science, basic research and development, quantum computing and exascale computing.

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.